<?xml version="1.0" encoding="UTF-8"?>
<ref id="B160-vaccines-08-00224">
 <label>160.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luo</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Tocilizumab treatment in COVID-19: A single center experience</article-title>
  <source>J. Med. Virol.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1002/jmv.25801</pub-id>
 </element-citation>
</ref>
